Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-BROMO-ISOQUINOLINE-1-CARBONITRILE is a brominated isoquinoline derivative with the molecular formula C9H5BrN2, featuring a carbonitrile group. It is a solid compound that is light sensitive and requires careful handling and storage to prevent degradation.

27224-09-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 27224-09-5 Structure
  • Basic information

    1. Product Name: 4-BROMO-ISOQUINOLINE-1-CARBONITRILE
    2. Synonyms: 4-BROMO-ISOQUINOLINE-1-CARBONITRILE
    3. CAS NO:27224-09-5
    4. Molecular Formula: C10H5BrN2
    5. Molecular Weight: 233.06
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 27224-09-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 375.328°C at 760 mmHg
    3. Flash Point: 180.792°C
    4. Appearance: /
    5. Density: 1.661g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.703
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. CAS DataBase Reference: 4-BROMO-ISOQUINOLINE-1-CARBONITRILE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-BROMO-ISOQUINOLINE-1-CARBONITRILE(27224-09-5)
    12. EPA Substance Registry System: 4-BROMO-ISOQUINOLINE-1-CARBONITRILE(27224-09-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 27224-09-5(Hazardous Substances Data)

27224-09-5 Usage

Uses

Used in Pharmaceutical Industry:
4-BROMO-ISOQUINOLINE-1-CARBONITRILE is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4-BROMO-ISOQUINOLINE-1-CARBONITRILE serves as an intermediate in the production of agrochemicals. Its incorporation into these compounds can contribute to the development of effective pesticides or other agricultural products.
Used in Organic Compounds Production:
4-BROMO-ISOQUINOLINE-1-CARBONITRILE is utilized in the synthesis of other organic compounds, expanding its applications across various chemical domains. Its versatility as a building block facilitates the creation of a wide range of molecules for different purposes.
Used in Chemical Reactions as a Building Block:
As a building block in chemical reactions, 4-BROMO-ISOQUINOLINE-1-CARBONITRILE enables the formation of complex molecules and contributes to the advancement of organic chemistry. Its presence in reactions can lead to the discovery of new compounds with unique properties and applications.

Check Digit Verification of cas no

The CAS Registry Mumber 27224-09-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,2,2 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 27224-09:
(7*2)+(6*7)+(5*2)+(4*2)+(3*4)+(2*0)+(1*9)=95
95 % 10 = 5
So 27224-09-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H5BrN2/c11-9-6-13-10(5-12)8-4-2-1-3-7(8)9/h1-4,6H

27224-09-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-bromoisoquinoline-1-carbonitrile

1.2 Other means of identification

Product number -
Other names 1-Cyano-4-bromoisochinolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27224-09-5 SDS

27224-09-5Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

-

Paragraph 0520; 0538-0539, (2017/07/05)

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 109, (2012/02/15)

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 198-199, (2011/06/16)

This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 111, (2011/06/16)

The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 106, (2011/07/07)

The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 174, (2010/11/04)

This disclosure concerns novel compounds of Formula (I) or Formula (II) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 161, (2010/12/26)

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 119, (2010/12/26)

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Hepatitis C Virus Inhibitors

-

Page/Page column 62, (2010/10/19)

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.

Hepatitis C Virus Inhibitors

-

Page/Page column 54, (2009/09/28)

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27224-09-5